Yazar "Tekin, Atilla" seçeneğine göre listele

Listeleniyor 1 - 6 / 6
  • [ X ]
    Öğe
    Depression and anxiety disorder comorbidity in patients with obstructive sleep apnea syndrome (OSAS)
    (Informa Healthcare, 2012) Bakim, Bahadir; Ertekin, Hulya; Karamustafalioglu, Oguz; Tekin, Atilla; Yavuz, Burcu Gokasan; Yayla, Sinan
    [Anstract Not Available]
  • [ X ]
    Öğe
    Efficacy of High Frequency [10 Hz] Repetitive Transcranial Magnetic Stimulation of the Primary Motor Cortex in Patients with Fibromyalgia Syndrome: A Randomized, Double Blind, Sham-Controlled Trial
    (Informa Healthcare, 2014) Tekin, Atilla; Ozdil, Esra; Guleken, Mehemet Diyaddin; Iliser, Resat; Bakim, Bahadir; Oncu, Julide; Cevik, Mehmet
    Objectives: Repetitive transcranial magnetic stimulation [rTMS] of the cerebral cortex has been tested as a treatment tool for various neurological and psychiatric diseases and other painful disorders. Our objectives were to determine whether high-frequency rTMS applied to the primary motor cortex could decrease pain intensity and influence the quality of life in patients with fibromyalgia syndrome [FMS]. Design: Fifty two patients with FMS were randomized to real [n = 27] or sham [n = 25] treatment groups. Ten consecutive sessions of rTMS were given to each of the patients. All patients were evaluated with the Structured Clinical Interview from the Diagnostic and Statistical Manual of Mental Disorders before treatment. The level of pain and the mood status were assessed with a visual analog scale and the Montgomery Asberg Rating Scale, respectively. The Turkish version of the World Health Quality of Life-BREF instrument was used to evaluate the quality of life. Results: The decrease of pain scale scores was found to be significantly greater among the real rTMS group than among those in the sham group [p<0.001]. Also the life quality physical subscale score improvement was significantly greater among those in the real rTMS therapy group than among those in the sham treatment group [p<0.001]. A strong relationship was found betweeen the decrease of pain levels in the real rTMS treated patients and the life quality physical subscale score improvement [R-2=0.419 and p<0.001]. Conclusions: These findings suggest that high-frequency rTMS application to the primary motor cortex could have an analgesic effect. Therefore, rTMS may be an alternative therapeutic option in FMS.
  • [ X ]
    Öğe
    Mania with psychotic feature induced by the use of pramipexole in Parkinson's disease: A case report
    (Turkish Association of Nervous and Mental Health, 2014) Meriç, Ceren; Pirdogan, Efruz; Günday Toker, Ömür; Tekin, Atilla; Bakim, Bahadir; Çelik, Selime
    Parkinson's disease (PD), which is frequently accompanied by psychiatric symptoms, is a neurodegenerative disease characterized by movement disorders. Psychiatric symptoms may be the direct result of PD, comorbid pathologies, or its pharmacotherapy. Pramipexole, as other dopamine agonists used in the treatment of PD, has a tendency to induce psychotic and manic symptoms due to central dopaminergic stimulation. Herein we present a PD patient that had mania with psychotic feature due to dopamine agonist treatment, which is not commonly reported.
  • [ X ]
    Öğe
    Mania with Psychotic Feature Induced by the use of Pramipexole in Parkinson's Disease: A Case Report
    (Turkiye Sinir Ve Ruh Sagligi Dernegi, 2014) Meric, Ceren; Pirdogan, Efruz; Toker, Omur Gunday; Tekin, Atilla; Bakim, Bahadir; Celik, Selime
    Parkinson's disease, a neurodegenerative disorder characterized by movement abnormalities, is frequently complicated by psychiatric syndromes. Psychiatric symptoms may be the direct result of PD, its co-morbid pathologies, or occur as a side effect of its pharmacotherapy. Pramipexole, like other dopamine agonists for treating Parkinson's disease, has a tendency to induce psychotic and manic symptoms due to central dopaminergic stimulation. In this article, mania with psychotic feature induced by the use of dopamine agonists which is not observed frequently in the literature will be discussed.
  • [ X ]
    Öğe
    Parkinson hastalığında pramipeksol kullanımına bağlı psikotik özellikli mani: Bir olgu sunumu
    (2014) Meriç, Ceren; Pirdoğan, Efruz; Günday, Ömür Toker; Tekin, Atilla; Çelik, Selime; Bakım, Bahadır
    Parkinson hastalığı, psikiyatrik belirtilerin sıklıkla eşlik ettiği, hareket bozuklukları ile belirli bir nörodejeneratif hastalıktır. Psikiyatrik belir- tiler, hastalığın doğrudan sonucu olarak ortaya çıkabileceği gibi, eşlik eden başka patolojilere veya tedavide kullanılan ilaçlara bağlı olarak da ortaya çıkabilir. Pramipeksol, Parkinson hastalığının tedavisinde kul- lanılan diğer dopamin agonistleri gibi, merkezi dopaminerjik uyarıma bağlı psikotik ve manik belirtilerin ortaya çıkmasına sebep olabilir. Ya- zında sık vurgulanmadığı gözlenen dopamin agonisti kullanımına bağlı psikotik özellikli mani, bu yazıda bir olgu üzerinden tartışılacaktır.
  • [ X ]
    Öğe
    Psychiatric Comorbidity in Patients with Conversion Disorder and Prevalence of Dissociative Symptoms
    (Routledge Journals, Taylor & Francis Ltd, 2015) Yayla, Sinan; Bakim, Bahadir; Tankaya, Onur; Ozer, Omer Akil; Karamustafalioglu, Oguz; Ertekin, Hulya; Tekin, Atilla
    The 1st objective of the current study was to investigate the frequency and types of dissociative symptoms in patients with conversion disorder (CD). The 2nd objective of the current study was to determine psychiatric comorbidity in patients with and without dissociative symptoms. A total of 54 consecutive consenting patients primarily diagnosed with CD according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, criteria who were admitted to the psychiatric emergency outpatient clinic of Sisli Etfal Research and Teaching Hospital (Istanbul, Turkey) were included in the study. The Structured Clinical Interview for DSM-IV Axis I Disorders, Structured Interview for DSM-IV Dissociative Disorders, and Dissociative Experiences Scale were administered. Study groups consisted of 20 patients with a dissociative disorder and 34 patients without a diagnosis of any dissociative disorder. A total of 37% of patients with CD had any dissociative diagnosis. The prevalence of dissociative disorders was as follows: 18.5% dissociative disorder not otherwise specified, 14.8% dissociative amnesia, and 3.7% depersonalization disorder. Significant differences were found between the study groups with respect to comorbidity of bipolar disorder, past hypomania, and current and past posttraumatic stress disorder (ps = .001, .028, .015, and .028, respectively). Overall comorbidity of bipolar disorder was 27.8%. Psychiatric comorbidity was higher and age at onset was earlier among dissociative patients compared to patients without dissociative symptoms. The increased psychiatric comorbidity and early onset of conversion disorder found in patients with dissociative symptoms suggest that these patients may have had a more severe form of conversion disorder.